JEANETTE LUKE: Open Payments
NPI 1780318238 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525 in 28 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $729 · 2025 $525
Food & beverage: $525
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $160 |
| Lilly USA, LLC | 3 | $71 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $67 |
| Vanda Pharmaceuticals Inc. | 2 | $49 |
| Exact Sciences Corporation | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Astellas Pharma US Inc | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $17 |
Products named: QULIPTA, CAPLYTA, FANAPT, MOUNJARO, VRAYLAR, AIRSUPRA, ZEPBOUND, Veozah.
Industry payments across AZ — which companies pay providers there.
